<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04941508</url>
  </required_header>
  <id_info>
    <org_study_id>17300621</org_study_id>
    <nct_id>NCT04941508</nct_id>
  </id_info>
  <brief_title>Mother's Recorded Voice Versus Dexmedetomidine on Postoperative Agitation</brief_title>
  <official_title>Mother's Recorded Voice: a Neglected Therapeutic Stance for Pediatric Postoperative Agitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the efficacy of mother's recorded voice versus&#xD;
      dexmedetomidine injection on postoperative agitation in children undergoing elective surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A written informed consent will be taken from the patients' legal guardians.Patients will be&#xD;
      assigned randomly to three groups (30 subjects each) to be anesthetized and either randomly&#xD;
      assigned to listen to the mother's recorded voice at 2 times (in the holding area 3 minutes&#xD;
      before induction of anesthesia till induction of anesthesia is ended) and (during emergence&#xD;
      from anesthesia till complete recovery) (Group M) or will be given a single bolus of&#xD;
      dexmedetomidine 0.2 µ/kg IV at 2 times (in the holding area 3 minutes before induction of&#xD;
      anesthesia) and (at the end of surgery) (Group D) or given the same volume of saline IV at 2&#xD;
      times (in the holding area 3 minutes before induction of anesthesia) and (at the end of&#xD;
      surgery) (Group C).To keep blinding, group M will be injected IV with the same volume of&#xD;
      saline at the same 2 times as in groups D &amp; C while in groups D &amp; C, headphones will be&#xD;
      putted as in group M at the same 2 times with no recorded voice.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 25, 2021</start_date>
  <completion_date type="Actual">November 5, 2021</completion_date>
  <primary_completion_date type="Actual">November 3, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pediatric anesthesia of emergence delirium (PAED) score</measure>
    <time_frame>2 hours Postoperative</time_frame>
    <description>Emergence delirium (ED) will be measured by the pediatric anesthesia of emergence delirium (PAED).The scores for each of the five listed behaviours(makes eye contact with caregiver, actions are purposeful,aware of surroundings, restless and inconsolable) are added to achieve a total score (maximum score of 20). A score of &gt;12 yields 100% sensitivity and 94.5% specificity for the diagnosis of ED</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Face, Legs, Activity, Cry, and Consolability (FLACC) score</measure>
    <time_frame>24 hours Postoperative</time_frame>
    <description>Pain will be measured by Face, Legs, Activity, Cry, and Consolability (FLACC) score ranging from 0 to 10 where 0= relaxed and no pain, 1-3= mild pain/discomfort, 4-6= moderate pain, 7-10= severe discomfort/pain.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Agitation, Emergence</condition>
  <arm_group>
    <arm_group_label>Mother's recorded voice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children will be exposed to the mother's voice.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine IV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children will be given dexmedetomidine injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline placebo IV</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Children will be given normal saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>the mother's recorded voice</intervention_name>
    <description>Children will be assigned to listen to the mother's recorded voice at 2 times (in the holding area 3 minutes before induction of anesthesia till induction of anesthesia is ended) and (during emergence from anesthesia till complete recovery).</description>
    <arm_group_label>Mother's recorded voice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Children will be given a single bolus of dexmedetomidine 0.2 µ/kg IV at 2 times (in the holding area 3 minutes before induction of anesthesia) and (at the end of surgery).</description>
    <arm_group_label>Dexmedetomidine IV</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>saline 0.9% placebo</intervention_name>
    <description>Children will be given the same volume of saline at 2 times (in the holding area 3 minutes before induction of anesthesia) and (at the end of surgery).</description>
    <arm_group_label>Saline placebo IV</arm_group_label>
    <other_name>Normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children (age 4-9 years)&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status (ASA) I-II who will be listed&#xD;
             for outpatient elective surgery under general anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Developmental delays&#xD;
&#xD;
          -  Neurological diseases&#xD;
&#xD;
          -  Deafness&#xD;
&#xD;
          -  Hearing impairment&#xD;
&#xD;
          -  Maternal mutism&#xD;
&#xD;
          -  Absence of the mother&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>9 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar Soliman, MD</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assiut university hospital</name>
      <address>
        <city>Assiut</city>
        <zip>Assuit university</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omar Soliman</name>
      <address>
        <city>Assuit</city>
        <zip>Assuit universi</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Manyande A, Cyna AM, Yip P, Chooi C, Middleton P. Non-pharmacological interventions for assisting the induction of anaesthesia in children. Cochrane Database Syst Rev. 2015 Jul 14;(7):CD006447. doi: 10.1002/14651858.CD006447.pub3. Review.</citation>
    <PMID>26171895</PMID>
  </results_reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 15, 2021</study_first_submitted>
  <study_first_submitted_qc>June 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2021</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Omar Makram Soliman</investigator_full_name>
    <investigator_title>Lecturer of anesthesia and ICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

